Avenue Therapeutics Stock Five Year Return

ATXI Stock  USD 1.77  0.03  1.67%   
Avenue Therapeutics fundamentals help investors to digest information that contributes to Avenue Therapeutics' financial success or failures. It also enables traders to predict the movement of Avenue Stock. The fundamental analysis module provides a way to measure Avenue Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avenue Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Avenue Therapeutics Company Five Year Return Analysis

Avenue Therapeutics' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.

Five Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

More About Five Year Return | All Equity Analysis

Avenue Five Year Return Driver Correlations

Understanding the fundamental principles of building solid financial models for Avenue Therapeutics is extremely important. It helps to project a fair market value of Avenue Stock properly, considering its historical fundamentals such as Five Year Return. Since Avenue Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avenue Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avenue Therapeutics' interrelated accounts and indicators.
0.940.920.51-0.87-0.20.53-0.460.35-0.340.091.00.520.1-0.1-0.1-0.050.12
0.941.00.6-0.95-0.490.4-0.60.62-0.64-0.160.940.60.33-0.35-0.350.2-0.13
0.921.00.62-0.94-0.510.39-0.620.64-0.66-0.190.920.620.38-0.37-0.370.26-0.16
0.510.60.62-0.71-0.750.25-0.960.77-0.48-0.220.511.00.63-0.72-0.720.42-0.17
-0.87-0.95-0.94-0.710.63-0.360.69-0.730.660.11-0.87-0.71-0.470.540.53-0.190.08
-0.2-0.49-0.51-0.750.630.110.82-0.990.820.55-0.2-0.74-0.860.920.93-0.570.52
0.530.40.390.25-0.360.11-0.23-0.010.10.040.530.25-0.34-0.12-0.12-0.170.06
-0.46-0.6-0.62-0.960.690.82-0.23-0.850.550.46-0.46-0.96-0.640.780.78-0.470.42
0.350.620.640.77-0.73-0.99-0.01-0.85-0.86-0.550.350.770.81-0.9-0.90.57-0.52
-0.34-0.64-0.66-0.480.660.820.10.55-0.860.46-0.34-0.48-0.650.690.69-0.660.44
0.09-0.16-0.19-0.220.110.550.040.46-0.550.460.09-0.2-0.40.470.49-0.491.0
1.00.940.920.51-0.87-0.20.53-0.460.35-0.340.090.520.1-0.1-0.1-0.050.12
0.520.60.621.0-0.71-0.740.25-0.960.77-0.48-0.20.520.63-0.72-0.710.41-0.16
0.10.330.380.63-0.47-0.86-0.34-0.640.81-0.65-0.40.10.63-0.71-0.720.48-0.38
-0.1-0.35-0.37-0.720.540.92-0.120.78-0.90.690.47-0.1-0.72-0.711.0-0.490.44
-0.1-0.35-0.37-0.720.530.93-0.120.78-0.90.690.49-0.1-0.71-0.721.0-0.490.46
-0.050.20.260.42-0.19-0.57-0.17-0.470.57-0.66-0.49-0.050.410.48-0.49-0.49-0.48
0.12-0.13-0.16-0.170.080.520.060.42-0.520.441.00.12-0.16-0.380.440.46-0.48
Click cells to compare fundamentals
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition

Avenue Return On Tangible Assets

Return On Tangible Assets

(5.89)

As of now, Avenue Therapeutics' Return On Tangible Assets are increasing as compared to previous years.
According to the company disclosure, Avenue Therapeutics has a Five Year Return of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Avenue Therapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Avenue Therapeutics from analyzing Avenue Therapeutics' financial statements. These drivers represent accounts that assess Avenue Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Avenue Therapeutics' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap1.8B4.1B11.3B7.4B6.6B4.7B
Enterprise Value1.8B4.1B11.3B7.4B6.6B4.7B

Avenue Fundamentals

About Avenue Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Avenue Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avenue Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avenue Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Avenue Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avenue Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avenue Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avenue Therapeutics Stock:
Check out Avenue Therapeutics Piotroski F Score and Avenue Therapeutics Altman Z Score analysis.
For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Earnings Share
24.78
Return On Assets
(2.01)
Return On Equity
(5.35)
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.